CA2764653A1 — Tetracyclic compounds
Assigned to Chugai Pharmaceutical Co Ltd · Expires 2010-12-16 · 15y expired
What this patent protects
Provided is a therapeutic and preventive agent effective against diseases accompanied by an abnormality of ALK, such as cancers, cancerous metastases, depression, or cognitive dysfunction, the agent containing an ALK-inhibitory compound. The agent comprises a medicinal compositio…
USPTO Abstract
Provided is a therapeutic and preventive agent effective against diseases accompanied by an abnormality of ALK, such as cancers, cancerous metastases, depression, or cognitive dysfunction, the agent containing an ALK-inhibitory compound. The agent comprises a medicinal composition containing a compound represented by general formula (I) [with respect to the symbols in the formula, see the definitions given in the description], a salt of the compound, or a solvate of either.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.